Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ORIFARM GROUP A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   0.6% 2.6% 1.7% 1.5% 1.4% 2.6% 4.7% 4.5%   Credit score (0-100)   97 61 71 76 76 61 45 47   Credit rating   AA BBB A A A BBB BBB BBB   Credit limit (kEUR)   16,022.5 0.3 130.8 734.9 1,301.1 0.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kEUR)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   13,878 8,627 1,361 3,437 3,664 3,791 3,791 3,791   Gross profit   13,891 -11,772 -681 11,650 12,836 1,995 0.0 0.0   EBITDA   -2,903 -24,222 -22,150 -14,384 -13,528 -28,812 0.0 0.0   EBIT   -4,691 -26,109 -25,814 -20,020 -19,833 -36,640 0.0 0.0   Pre-tax profit (PTP)   34,118.0 22,335.0 20,563.0 19,281.0 12,579.0 -2,995.0 0.0 0.0   Net earnings   34,737.0 25,518.0 28,690.0 25,689.0 22,442.0 3,260.0 0.0 0.0   Pre-tax profit without non-rec. items   34,118 22,335 20,563 19,281 12,579 -2,995 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kEUR)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   1,501 2,859 4,888 4,661 4,334 3,427 0.0 0.0   Shareholders equity total   167,930 148,963 169,527 187,233 208,098 374,171 328,002 328,002   Interest-bearing liabilities   96,034 191,030 627,293 779,911 851,706 657,636 0.0 0.0   Balance sheet total (assets)   272,117 353,106 855,502 1,022,745 1,104,465 1,059,474 328,002 328,002   Net Debt   96,027 191,023 627,271 779,414 851,692 657,610 -326,761 -326,761     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   13,878 8,627 1,361 3,437 3,664 3,791 3,791 3,791   Net sales growth   38.6% -37.8% -84.2% 152.5% 6.6% 3.5% 0.0% 0.0%   Gross profit   13,891 -11,772 -681 11,650 12,836 1,995 0.0 0.0   Gross profit growth   36.9% 0.0% 94.2% 0.0% 10.2% -84.5% -100.0% 0.0%   Employees   65 83 125 174 202 203 0 0   Employee growth %   14.0% 27.7% 50.6% 39.2% 16.1% 0.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   272,117 353,106 855,502 1,022,745 1,104,465 1,059,474 328,002 328,002   Balance sheet change%   37.6% 29.8% 142.3% 19.5% 8.0% -4.1% -69.0% 0.0%   Added value   -2,903.0 -24,222.0 -22,150.0 -14,384.0 -14,197.0 -28,812.0 0.0 0.0   Added value %   -20.9% -280.8% -1,627.5% -418.5% -387.5% -760.0% 0.0% 0.0%   Investments   -744 6,562 6,639 -5,720 -7,562 -12,446 -16,004 0   Net sales trend   2.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   -20.9% -280.8% -1,627.5% -418.5% -369.2% -760.0% 0.0% 0.0%   EBIT %   -33.8% -302.6% -1,896.7% -582.5% -541.3% -966.5% 0.0% 0.0%   EBIT to gross profit (%)   -33.8% 221.8% 3,790.6% -171.8% -154.5% -1,836.6% 0.0% 0.0%   Net Earnings %   250.3% 295.8% 2,108.0% 747.4% 612.5% 86.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   263.2% 317.7% 2,377.2% 911.4% 784.6% 292.5% 0.0% 0.0%   Pre tax profit less extraordinaries %   245.8% 258.9% 1,510.9% 561.0% 343.3% -79.0% 0.0% 0.0%   ROA %   15.3% 8.3% 6.6% 5.1% 10.4% 7.1% 0.0% 0.0%   ROI %   15.6% 8.5% 6.9% 5.4% 10.8% 7.3% 0.0% 0.0%   ROE %   22.9% 16.1% 18.0% 14.4% 11.4% 1.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   61.7% 42.2% 19.8% 18.3% 18.8% 35.3% 100.0% 100.0%   Relative indebtedness %   746.9% 2,336.2% 49,637.6% 24,009.2% 24,284.3% 17,986.6% 0.0% 0.0%   Relative net indebtedness %   746.9% 2,336.1% 49,636.0% 23,994.8% 24,283.9% 17,985.9% -8,619.4% -8,619.4%   Net int. bear. debt to EBITDA, %   -3,307.9% -788.6% -2,831.9% -5,418.6% -6,295.8% -2,282.4% 0.0% 0.0%   Gearing %   57.2% 128.2% 370.0% 416.5% 409.3% 175.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.2% 2.5% 4.7% 4.1% 12.0% 10.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.9 0.7 0.6 1.2 1.4 1.3 0.0 0.0   Current Ratio   1.1 0.8 0.7 1.3 1.4 1.3 0.0 0.0   Cash and cash equivalent   7.0 7.0 22.0 497.0 14.0 26.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.4 1.9 84.7 8.1 99.4 3,249.7 0.0 0.0   Trade creditors turnover (days)   20.5 52.8 249.6 270.6 24.4 106.9 0.0 0.0   Current assets / Net sales %   701.0% 1,701.9% 5,766.7% 8,979.2% 11,929.1% 10,256.7% 8,619.4% 8,619.4%   Net working capital   8,265.0 -39,759.0 -30,168.0 66,715.0 127,118.0 80,889.0 0.0 0.0   Net working capital %   59.6% -460.9% -2,216.6% 1,941.1% 3,469.4% 2,133.7% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   214 104 11 20 18 19 0 0   Added value / employee   -45 -292 -177 -83 -70 -142 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -45 -292 -177 -83 -67 -142 0 0   EBIT / employee   -72 -315 -207 -115 -98 -180 0 0   Net earnings / employee   534 307 230 148 111 16 0 0